Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FACBC PET Imaging for Chemotherapy Response in Prostate Cancer
NCT02830880Phase 2Completed
- Sponsor
- Emory University
- Start
- Jul 2016
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluciclovine f 18 in prostate cancer (PCa), sponsored by Emory University. Started Jul 2016; status: completed.
02
Drugs
fluciclovine f 18
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02830880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02830880.